Topamax, manufactured and produced by Janssen Pharmaceuticals, Inc., was designed to treat neurological conditions, such as seizures and migraines. It has been used off-label to treat a wide range of related conditions that include bipolar disorder, post-traumatic stress disorder, depression, infantile spasm and autism.
The drug has been linked to complications and birth defects in the children of women who ingested the drug during pregnancy, especially in the first trimester. These risks include cleft palate, cleft lip, heart defects, spina bifida, hypospadias and other congenital malformations.
In March 2011, the FDA issued a statement warning doctors and patients of the potential risks to infants of women treated with the drug during pregnancy. The agency reclassified the drug as Pregnancy Category D, showing positive evidence of fetal risk.
It is only advised that the drug be taken on a case-by-case basis, where the doctor determines that the mother's medical need outweighs the potential risk to the child.
At Alexander Shunnarah, we fight to achieve justice for families and children who have been hurt or impacted by the use of Topamax and other antiepileptic medications. With our significant participation in the Topamax litigation, we are aggressively representing individuals against Janssen.
If you or a loved one has suffered serious complications or side effects as a result of taking Topamax, contact our law firm today. Corrective surgery and treatment are expensive, and we advocate to recover compensation for pain, as well as these costly procedures. We have the personnel and financial resources to see this case through to the end, achieving results.
If you have been hurt by a failure of the drug companies to disclose vital information about a drug, its usage or side effects, call Alexander Shunnarah Personal Injury Attorneys today at 1-800-229-7989.